The Japan Diagnostic Imaging Market was valued at $2155.4 Million in 2025 and projected to reach to $3045.6 Million by 2030, representing a compound annual growth rate of 7.2%. Japan's diagnostic imaging market is positioned for sustained growth through 2030, driven by the convergence of demographic shifts, technological innovation, and healthcare policy support.
Japan's rapidly aging demographic, with over 29% of the population aged 65+, is significantly increasing the demand for diagnostic imaging services for age-related conditions including cancer, cardiovascular disease, and neurological disorders.
Japanese healthcare providers are investing heavily in cutting-edge imaging technologies such as 3D ultrasound, hybrid PET-CT systems, and AI-integrated diagnostic platforms to enhance diagnostic accuracy and patient outcomes.
Japan's government-backed healthcare modernization programs and emphasis on early disease detection through comprehensive screening programs are accelerating the adoption of diagnostic imaging across hospitals and clinics nationwide.
With a CAGR of 7.2% from 2025 to 2030, Japan's diagnostic imaging market is expanding faster than the global average of 4.4%, reflecting the country's commitment to healthcare excellence and technological advancement.
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | ULTRA-HIGH-FIELD (Field Strength) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 4.4% from 2025 to 2030 |
| Largest Segment | HOSPITALS (End User) |
| Market Size Base Year (Billions) | ~USD 26.53 (2025) |
| Revenue Forecast (Billions) | ~USD 32.9 (2030) |
| Segments Covered | Application, Modality, Type, Technology, Portability, Architecture, Field Strength, End User |
8 segment dimensions are covered across the global market.
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| TOSHIBA CORPORATION | Japan | Private Company | Energy Systems & Solutions,Infrastructure Systems & Solutions,Electronic Devices and Storage Solutions, |
| AT&S | Canada | Public Company | Custom automated manufacturing and assembly systems,Pre- and post-automation lifecycle services,Contract manufacturing and integration services, |
| HEALTHFUSION INC. | United States | Private Company | MediTouch EHR (clinical module),Practice Management & Scheduling,Clearinghouse & Revenue Cycle Transactions, |
| UNILABS | Switzerland | Private Company | Core laboratory testing,Medical imaging,Pathology and centres of excellence, |
| UNITED IMAGING HEALTHCARE CO., LTD. | China | Public Company | Magnetic Resonance Imaging,Computed Tomography,Molecular Imaging (PET/CT, SPECT), |
| SIEMENS HEALTHINEERS | Germany | Public Company | |
| GE HEALTHCARE | United States | Public Company | Imaging,Advanced Visualization Solutions (AVS),Patient Care Solutions (PCS), |
| KONINKLIJKE PHILIPS N.V. | Netherlands | Public Company | Diagnostic Imaging (MR, CT, X-ray, Ultrasound),Image Guided Therapy Systems and Devices,Monitoring and Enterprise Informatics, |
| FUJIFILM CORPORATION | Japan | Public Company | Healthcare (medical systems, CDMO, pharma, regenerative, cosmetics/supplements),Electronics (display, semiconductors, storage, industrial equipment, fine chemicals),Business Innovation (office equipment, document services, graphic communications, inkjet), |
| CANON | Japan | Public Company | Printing Business Unit (office, production, large-format, document solutions),Imaging Business Unit (cameras, lenses, network cameras, cinema/broadcast),Medical Business Unit (diagnostic imaging, ophthalmology, IVD, healthcare IT), |
| SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. | China | Public Company | Patient monitoring, anesthesia, ventilators, and defibrillation,Ultrasound and radiology imaging,In-vitro diagnostics (CLIA, chemistry, hematology), |
| ESAOTE S.P.A | Italy | Private Company | Ultrasound diagnostic imaging systems,Dedicated MRI systems (MSK, weight-bearing, head),Healthcare IT software (radiology, cardiology, oncology), |
| SHIMADZU CORPORATION | Japan | Public Company | Analytical and Measuring Instruments,Medical Systems (Imaging and Fluorescence),Industrial and Vacuum Machinery, |
| HOLOGIC, INC. | United States | Private Company | Diagnostics (Panther/Aptima and related assays),Breast Health (3D mammography, biopsy, imaging software, service),GYN Surgical (MyoSure, NovaSure, Acessa, Fluent, CoolSeal), |
| AGFA-GEVAERT GROUP | Belgium | Public Company | Healthcare enterprise imaging platform and software,Diagnostic imaging hardware, X-ray film, and hardcopy,Sign and display and packaging printers, inks, and software, |
| CURVEBEAM AI, LTD. | United States | Public Company | Lower extremity weight-bearing CT (LineUP, pedCAT, pedCAT Premium, TALAS, Autometrics, Axiometrics),HiRise bilateral weight-bearing CT (multi-joint, including hip and full lower limb),Upper extremity and general point-of-care CT (InReach, OSSView, CubeVue, custom cloud platforms), |
Toshiba Corporation is a private company founded in 1875 and based in Japan with 106,648 employees.
AT&S is a public company founded in 1978 and based in Canada with 7,000 employees.
HealthFusion Inc. is a private company founded in 1998 and based in the United States with 120 employees.
Unilabs is a private company founded in 1987 and based in Switzerland with 1,897 employees.
United Imaging Healthcare Co., Ltd. is a public company founded in 2011 and based in China with 8,703 employees.
Siemens Healthineers is a public company founded in 1896 and based in Germany with 72,369 employees.
GE Healthcare is a public company founded in 2022 and based in the United States with 54,000 employees.
Koninklijke Philips N.V. is a public company founded in 1891 and based in the Netherlands with 64,317 employees.
Fujifilm Corporation is a public company founded in 1934 and based in Japan with 73,526 employees.
Canon is a public company founded in 1933 and based in Japan with 165,547 employees.
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. is a public company founded in 1991 and based in China with 21,288 employees.
Esaote S.p.A. is a private company founded in 1982 and based in Italy with 1,067 employees.
Shimadzu Corporation is a public company founded in 1875 and based in Japan with 14,649 employees.
Hologic, Inc. is a private company founded in 1985 and based in the United States with 7,070 employees.
Agfa-Gevaert Group is a public company founded in 1867 and based in Belgium with 4,211 employees.
CurveBeam AI, Ltd. is a public company founded in 2009 and based in the United States with 50 employees.
Japan's diagnostic imaging market is valued at USD 2,155.4 million in 2025 and is projected to reach USD 3,045.6 million by 2030.
Japan's diagnostic imaging market is growing at a compound annual growth rate (CAGR) of 7.2% from 2025 to 2030.
Key drivers include Japan's aging population, rising chronic disease prevalence, government healthcare investments, and adoption of AI-integrated imaging technologies.
MRI, CT scanners, and ultrasound systems are among the most demanded diagnostic imaging modalities in Japan due to their diagnostic accuracy and clinical applications.
Japan's 7.2% CAGR significantly exceeds the global diagnostic imaging market CAGR of 4.4%, reflecting stronger regional demand and healthcare investment.
The study involved four major activities in estimating the current size of the diagnostic imaging market. Exhaustive secondary research was done to collect information on the peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.
The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial diagnostic imaging market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
In the primary research process, various supply and demand sources were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the diagnostic imaging market. The primary sources from the demand side include medical OEMs, CDMOs, and service providers. Primary research was conducted to validate the market segmentation, identify key players, and gather insights on key industry trends & key market dynamics.
A breakdown of the primary respondents is provided below:
Note 1: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note 2: D-level executives include directors of operations, directors of finance, directors of marketing, and directors of product management
Note 3: C-level executives include chief executive officers, chief financial officers, chief operating officers, and chief marketing officers.
Note 4: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 2 billion, Tier 2 = USD 50 million to USD 2 billion, and Tier 3 = < USD 50 million.
To know about the assumptions considered for the study, download the pdf brochure
In this report, the size of the diagnostic imaging market was determined using the revenue share analysis of leading players. For this purpose, key players in the market were identified, and their revenues from the market business were determined through various insights gathered during the primary and secondary research phases. Secondary research included studying the annual and financial reports of the top market players. In contrast, primary research included extensive interviews with key opinion leaders, such as CEOs, directors, and key marketing executives.
Segmental revenues were calculated based on the revenue mapping of major product providers to calculate the global market value. This process involves the following steps:

After arriving at the overall market size from the market size estimation process explained above, the global diagnostic imaging market was split into segments and subsegments. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides. Additionally, the diagnostic imaging market was validated using top-down and bottom-up approaches.
Diagnostic imaging involves the use of various diagnostic modalities to visualize a patient’s anatomy. This market addresses the industry focusing on various technologies used for the detection, monitoring, and diagnosis of different medical conditions. Different imaging modalities include computed tomography (CT), ultrasound, X-ray imaging, MRI, nuclear imaging, and mammography technologies. These modalities help healthcare professionals to visualize the internal structure and other surrounding tissues. Diagnostic imaging equipment is primarily used in hospitals, diagnostic imaging centers, and ambulatory imaging centers.
Full forecast, segment splits, and company analysis for all Diagnostic Imaging Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report